Ascendis Pharma A/S
ASND212.110USD
-1.130-0.53%
收盤 12/16, 16:00（美東）報價延遲15分鐘
13.09B總市值
虧損本益比TTM
關於 Ascendis Pharma A/S 公司
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/S簡介
公司代碼ASND
公司名稱Ascendis Pharma A/S
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
員工數量- -
證券類型Depository Receipt
年結日Jan 28
公司地址Tuborg Boulevard 12
城市HELLERUP
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Denmark
郵編2900
電話4570222244
網址https://ascendispharma.dk/
公司代碼ASND
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
Ascendis Pharma A/S公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
地區USD
名稱
營收
佔比
North America
108.45M
68.62%
Europe
27.89M
17.65%
Rest of world
21.70M
13.73%
業務
地區
業務USD
名稱
營收
佔比
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
股東統計
更新時間: 12月4日 週四
更新時間: 12月4日 週四
持股股東
股東類型
持股股東
持股股東
佔比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
8.53%
Avoro Capital Advisors LLC
8.28%
Janus Henderson Investors
7.01%
Fidelity Management & Research Company LLC
6.68%
其他
52.84%
持股股東
持股股東
佔比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
8.53%
Avoro Capital Advisors LLC
8.28%
Janus Henderson Investors
7.01%
Fidelity Management & Research Company LLC
6.68%
其他
52.84%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
43.51%
Investment Advisor
36.00%
Venture Capital
16.92%
Hedge Fund
4.61%
Research Firm
2.38%
Private Equity
2.29%
Individual Investor
0.76%
Pension Fund
0.36%
Bank and Trust
0.01%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
523
68.62M
116.45%
+3.30K
2025Q3
540
68.73M
112.39%
+4.25M
2025Q2
515
64.43M
118.51%
-2.60M
2025Q1
495
67.05M
117.13%
-3.67M
2024Q4
471
65.26M
121.58%
+1.14M
2024Q3
461
64.02M
116.74%
+1.57M
2024Q2
446
62.31M
123.50%
-4.72K
2024Q1
440
62.32M
122.74%
-9.15M
2023Q4
415
61.74M
123.84%
-59.49K
2023Q3
401
61.90M
129.48%
-512.07K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
RA Capital Management, LP
10.28M
16.88%
--
--
Jun 30, 2025
Westfield Capital Management Company, L.P.
5.45M
8.95%
-27.86K
-0.51%
Jun 30, 2025
Avoro Capital Advisors LLC
4.98M
8.18%
-238.00K
-4.56%
Jun 30, 2025
Janus Henderson Investors
4.43M
7.27%
-59.16K
-1.32%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.18M
6.86%
-125.41K
-2.91%
Jun 30, 2025
Artisan Partners Limited Partnership
3.99M
6.55%
-266.20K
-6.25%
Jun 30, 2025
Capital International Investors
3.05M
5%
+172.14K
+5.99%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.58M
5.88%
+529.72K
+17.35%
Jun 30, 2025
MFS Investment Management
1.90M
3.11%
+23.62K
+1.26%
Jun 30, 2025
Wellington Management Company, LLP
918.10K
1.51%
+330.33K
+56.20%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Harbor Health Care ETF
17.71%
American Century Focused Dynamic Growth ETF
2.8%
AdvisorShares Dorsey Wright ADR ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.45%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.19%
First Trust Innovation Leaders ETF
1.18%
Putnam Sustainable Future ETF
1.11%
Main Thematic Innovation ETF
1.07%
查看更多
Harbor Health Care ETF
佔比17.71%
American Century Focused Dynamic Growth ETF
佔比2.8%
AdvisorShares Dorsey Wright ADR ETF
佔比2.62%
Virtus LifeSci Biotech Products ETF
佔比1.89%
Tema Heart & Health ETF
佔比1.45%
ProShares Ultra Nasdaq Biotechnology
佔比1.2%
Invesco Nasdaq Biotechnology ETF
佔比1.19%
First Trust Innovation Leaders ETF
佔比1.18%
Putnam Sustainable Future ETF
佔比1.11%
Main Thematic Innovation ETF
佔比1.07%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Ascendis Pharma A/S的前五大股東是誰？
Ascendis Pharma A/S的前五大股東如下：
RA Capital Management, LP持有股份：10.28M佔總股份比例：16.88%。
Westfield Capital Management Company, L.P.持有股份：5.45M佔總股份比例：8.95%。
Avoro Capital Advisors LLC持有股份：4.98M佔總股份比例：8.18%。
Janus Henderson Investors持有股份：4.43M佔總股份比例：7.27%。
Fidelity Management & Research Company LLC持有股份：4.18M佔總股份比例：6.86%。
RA Capital Management, LP持有股份：10.28M佔總股份比例：16.88%。
Westfield Capital Management Company, L.P.持有股份：5.45M佔總股份比例：8.95%。
Avoro Capital Advisors LLC持有股份：4.98M佔總股份比例：8.18%。
Janus Henderson Investors持有股份：4.43M佔總股份比例：7.27%。
Fidelity Management & Research Company LLC持有股份：4.18M佔總股份比例：6.86%。
Ascendis Pharma A/S的前三大股東類型是什麼？
Ascendis Pharma A/S 的前三大股東類型分別是：
RA Capital Management, LP
Westfield Capital Management Company, L.P.
Avoro Capital Advisors LLC
RA Capital Management, LP
Westfield Capital Management Company, L.P.
Avoro Capital Advisors LLC
有多少機構持有Ascendis Pharma A/S(ASND)的股份？
截至2025Q4，共有523家機構持有Ascendis Pharma A/S的股份，合計持有的股份價值約為68.62M，占公司總股份的116.45% 。與2025Q3相比，機構持股有所增加，增幅為4.06%。
哪個業務部門對Ascendis Pharma A/S的收入貢獻最大？
在FY2025Q2，Commercial sale of products業務部門對Ascendis Pharma A/S的收入貢獻最大，創收153.66M，占總收入的97.23% 。
